Catalyst Wire Dossier Catalyst Wire Dossier

Alpheon

recombinant human interferon alfa-2a · BioPartners GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Alpheon, covering 2006-06-28 to 2006-06-28. Get the full timeline:

Most recent: EMA Refused: Alpheon (recombinant human interferon alfa-2a) — BioPartners GmbH

See pricing